For Quick Alerts
For Daily Alerts

Lupin Hits 52-week Low on US Observations

By Religare

Shares of drug maker Lupiun fell over 1 per cent on the Bombay Stock Exchange, hitting 52-week low, after media report suggested that US FDA has issued Form 483 with three observations to company's Goa plant.

Lupin Hits 52-week Low on US Observations
Lupin: Quotes, News
BSE 583.85BSE Quote5.85 (-1.00%)
NSE 584.95NSE Quote4.7 (-0.80%)

Reacting to the news, shares of the company declined as much as 1.31 per cent to hit 52-week low of Rs 1319.60 apiece on the Bombay Stock Exchange. The scrip was currently trading at Rs 1323.05 against previous close price of Rs 1337.25.

In a similar fashion, stocks of company were trading 0.94 per cent lower at Rs 1,323.65 apiece on the National Stock Exchange.

Meanwhile, the broader benchmark BSE Sensex was trading at 29,860.02, down 169.72 points or 0.57 per cent, at 12:05 hour.

Read more about: lupin bse nse sensex nifty
Company Search
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more